Acute hepatitis associated with the use of levofloxacin

Clinical Therapeutics

Volumn 32, Issue 10, 2010, Pages 1733-1737

  Figueira Coelho, João ^a   Pereira, Olga ^a   Picado, Bárbara ^a   Mendonça, Paula ^a   Neves Costa, José ^a   Neta, Jorge ^a  

^a HOSPITAL CURRY CABRAL   (Portugal)

Author keywords

Acute hepatitis; Case report; Levofloxacin; Liver biopsy

Indexed keywords

AMINOTRANSFERASE; FLUTICASONE; LEVOFLOXACIN; PARACETAMOL; PREDNISOLONE; SALBUTAMOL; SALMETEROL; SIMVASTATIN;

ACUTE HEPATITIS; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC BRONCHITIS; COOMBS POSITIVE HEMOLYTIC ANEMIA; DISEASE EXACERBATION; DRUG USE; DRUG WITHDRAWAL; EMERGENCY WARD; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TOXICITY; MALE; PNEUMONIA;

ACUTE DISEASE; AGED; ANTI-BACTERIAL AGENTS; BIOPSY, NEEDLE; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER FUNCTION TESTS; MALE; OFLOXACIN; PNEUMONIA; TREATMENT OUTCOME;

EID: 78650618646     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.09.004     Document Type: Article

References (20)

1. Noel GJ A review of levofloxacin for the treatment of bacterial infections. Clin Med Ther. 2009, 1:433-458.
2. Kahn JB Latest industry information on the safety profile of levofloxacin in the US. Chemotherapy 2001, 47(Suppl 3):32-37. discussion.
3. Kahn JB Latest industry information on the safety profile of levofloxacin in the US. Chemotherapy 2001, 47(Suppl 3):44-48.
4. Carbon C Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 2001, 47(Suppl 3):9-14. discussion.
5. Carbon C Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 2001, 47(Suppl 3):44-48.
6. Karim A, Ahmed S, Rossoff LJ, et al. Possible levofloxacin- induced acute hepatocellular injury in a patient with chronic obstructive lung disease. Clin Infect Dis. 2001, 33:2088-2090.
7. Spahr L, Rubbia-Brandt L, Marinescu O, et al. Acute fatal hepatitis related to levofloxacin. J Hepatol. 2001, 35:308-309.
8. Schwalm JD, Lee CH Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. CMAJ. 2003, 168:847-848.
9. Coban S, Ceydilek B, Ekiz F, et al. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection. Ann Pharmacother. 2005, 39:1737-1740.
10. Carrascosa MF, Lucena MI, Andrade RJ, et al. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther. 2009, 31:1014-1019.
11. Assis DN, Navarro VJ Human drug hepatotoxicity: A contemporary clinical perspective. Expert Opin Drug Metab Toxicol. 2009, 5:463-473.
12. Pugh AJ, Barve AJ, Falkner K, et al. Drug-induced hepato- toxicity or drug-induced liver injury. Clin Liver Dis. 2009, 13:277-294.
13. Ramachandran R, Kakar S Histological patterns in liver disease. J Clin Pathol. 2009, 62:481-492.
14. O'Donnell JA, Gelone SP Fluoroquinolones. Infect Dis Clin North Am. 2000, 14:489-513.
15. O'Donnell JA, Gelone SP Fluoroquinolones. Infect Dis Clin North Am. 2000, 14:xi.
16. Lipsky BA, Baker CA Fluoroquinolone toxicity profile: A review focusing on newer agents. Clin Infect Dis. 1999, 28:352-364.
17. Levaquin (levofloxacin tablets, oral solution injection) [prescribing information] 2008, Ortho-McNeil-Janssen Pharmaceuticals, Inc, Raritan, NJ. http://www.ortho-mcneil.com/ortho-mcneil/shared/pi/levaquin.pdf.
18. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-245.
19. García-Cortés M, Lucena MI, Pachkoria K, et al. Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther. 2008, 27:780-789. Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatias Asociadas a Medicamentos, Geham).
20. Danan G, Benichou C Causality assessment of adverse reactions to drugs-I. A novel method based on the con- clusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 1993, 46:1323-1330.